Latest article about Israel’s NanoSynex (see here previously) and its antibiotic diagnosis test. The $11 million funding from investors, the IAA and Europe has helped it develop the product to test up to 20 patients at once and determine the correct antibiotic to use against bacteriological infections.
https://nocamels.com/2024/07/startup-fights-superbugs-antibiotic-resistance-with-rapid-testing/